Stoke To Participate In Pre-NDA FDA Meeting During 2H 2026 As It Plans To Initiate Planned Rolling NDA Submission For Zorevunersen In Q1 2027

뉴스 본문을 불러오고 있어요.

Stoke To Participate In Pre-NDA FDA Meeting During 2H 2026 As It Plans To Initiate Planned Rolling NDA Submission For Zorevunersen In Q1 2027 | 웨이프 WAPE

Stoke To Participate In Pre-NDA FDA Meeting During 2H 2026 As It Plans To Initiate Planned Rolling NDA Submission For Zorevunersen In Q1 2027

기사 요약

관련 종목

댓글 —